Scipher Medicine Presents New Data at the European League Against Rheumatism (EULAR) 2021 Further Validating PrismRA® Test
June 15, 2021 08:00 ET
|
Scipher Medicine Corporation
Molecular signature test predicts likelihood of non-response to adalimumab or etanercept, two of the world’s most expensive medications, in an independent validation cohort PrismRA demonstrates a more...
PMV Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights
November 13, 2020 08:00 ET
|
PMV Pharmaceuticals, Inc.
U.S. Food and Drug Administration (FDA) clearance of PMV Pharmaceutical’s investigational new drug application for its lead product candidate PC14586PMV Pharma lead product candidate PC14586 granted...